Evidence map›Paper›PMID 38576622›Full record

ArticleFrontiers in immunology2024

Disruption of IL-17-mediated immunosurveillance in the respiratory mucosa results in invasive

Jamie-Lee Mills, Ailin Lepletier, Victoria Ozberk, Jessica Dooley, Jacqualine Kaden, Ainslie Calcutt, Yongbao Huo, Allan Hicks, Ali Zaid, Michael F Good and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Identification of immunostimulatory antigens in Group AProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. T cells in Group AFrontiers in cellular and infection microbiology · 2026
    Review
  4. Article
  5. CD8Immunology and cell biology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Jamie-Lee MillsInstitute for Glycomics, Griffith University, Gold Coast, QLD, Australia.
Ailin LepletierInstitute for Glycomics, Griffith University, Gold Coast, QLD, Australia.
Victoria OzberkInstitute for Glycomics, Griffith University, Gold Coast, QLD, Australia.
Jessica DooleyInstitute for Glycomics, Griffith University, Gold Coast, QLD, Australia.
Jacqualine KadenInstitute for Glycomics, Griffith University, Gold Coast, QLD, Australia.
Ainslie CalcuttInstitute for Glycomics, Griffith University, Gold Coast, QLD, Australia.
Yongbao HuoInstitute for Glycomics, Griffith University, Gold Coast, QLD, Australia.
Allan HicksSchool of Pharmacy and Medical Sciences, Griffith University, Gold Coast, QLD, Australia.
Ali ZaidSchool of Pharmacy and Medical Sciences, Griffith University, Gold Coast, QLD, Australia.
Michael F GoodInstitute for Glycomics, Griffith University, Gold Coast, QLD, Australia.
Manisha PandeyInstitute for Glycomics, Griffith University, Gold Coast, QLD, Australia.
Griffith University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Methods: Here, we modeled single or repeated non-lethal intranasal (IN) Results: Immunocompetent mice that received a single Discussion: Our results demonstrated that IL-17 plays a critical role in preventing invasive disease following

Indexed as

Streptococcal InfectionsStreptococcus pyogenesAnimalsInterleukin-17MiceMonitoring, ImmunologicRespiratory MucosaIl17a protein, mouseInterleukin-17IL-17invasive streptococcal infectionmucosal infectionnatural immunityS. pyogenes

Identifiers

PMID38576622
PMCPMC10991685
OpenAlexW4393054015

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.